NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 313 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,311 | -28.0% | 2,558 | +85.1% | 0.00% | – |
Q2 2023 | $57,354 | -36.6% | 1,382 | -8.2% | 0.00% | – |
Q1 2023 | $90,510 | -9.7% | 1,505 | +10.2% | 0.00% | – |
Q4 2022 | $100,195 | -49.1% | 1,366 | -47.1% | 0.00% | – |
Q3 2022 | $197,000 | +6.5% | 2,584 | -2.6% | 0.00% | – |
Q2 2022 | $185,000 | -21.9% | 2,654 | -7.1% | 0.00% | – |
Q1 2022 | $237,000 | +31.7% | 2,857 | +18.9% | 0.00% | – |
Q4 2021 | $180,000 | -30.8% | 2,403 | +7.4% | 0.00% | – |
Q3 2021 | $260,000 | -64.6% | 2,237 | -32.4% | 0.00% | -100.0% |
Q2 2021 | $734,000 | +92.7% | 3,308 | +14.9% | 0.00% | 0.0% |
Q1 2021 | $381,000 | -20.0% | 2,878 | +4.4% | 0.00% | 0.0% |
Q4 2020 | $476,000 | -53.8% | 2,756 | -70.2% | 0.00% | -66.7% |
Q3 2020 | $1,030,000 | +87.6% | 9,252 | -0.2% | 0.00% | +200.0% |
Q2 2020 | $549,000 | -20.7% | 9,266 | -9.8% | 0.00% | -50.0% |
Q1 2020 | $692,000 | -22.6% | 10,274 | -3.2% | 0.00% | 0.0% |
Q4 2019 | $894,000 | +9.6% | 10,611 | -2.7% | 0.00% | 0.0% |
Q3 2019 | $816,000 | -0.7% | 10,911 | -16.1% | 0.00% | 0.0% |
Q2 2019 | $822,000 | +26.5% | 13,000 | -3.7% | 0.00% | 0.0% |
Q1 2019 | $650,000 | +43.8% | 13,500 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $452,000 | -33.6% | 13,500 | +3.8% | 0.00% | -50.0% |
Q3 2018 | $681,000 | +67.3% | 13,000 | 0.0% | 0.00% | +100.0% |
Q2 2018 | $407,000 | +43.8% | 13,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $283,000 | +7.6% | 13,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $263,000 | +1.9% | 13,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $258,000 | +49.1% | 13,000 | +30.0% | 0.00% | 0.0% |
Q2 2017 | $173,000 | +113.6% | 10,000 | 0.0% | 0.00% | – |
Q1 2017 | $81,000 | +2.5% | 10,000 | 0.0% | 0.00% | – |
Q4 2016 | $79,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |